Synlogic, Inc. (SYBX)
1.175
0.00 (0.00%)
USD |
OTCM |
Sep 08, 16:00
Synlogic Shareholders Equity (Quarterly) : 12.02M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.02M |
| March 31, 2026 | 12.55M |
| December 31, 2025 | 11.86M |
| September 30, 2025 | 10.32M |
| June 30, 2025 | 12.59M |
| March 31, 2025 | 13.09M |
| December 31, 2024 | 12.75M |
| September 30, 2024 | 13.11M |
| June 30, 2024 | 15.98M |
| March 31, 2024 | 13.32M |
| December 31, 2023 | 42.66M |
| September 30, 2023 | 43.40M |
| June 30, 2023 | 54.77M |
| March 31, 2023 | 68.71M |
| December 31, 2022 | 82.61M |
| September 30, 2022 | 100.43M |
| June 30, 2022 | 117.35M |
| March 31, 2022 | 132.29M |
| December 31, 2021 | 147.27M |
| September 30, 2021 | 161.58M |
| June 30, 2021 | 128.08M |
| March 31, 2021 | 109.05M |
| December 31, 2020 | 115.14M |
| September 30, 2020 | 120.50M |
| June 30, 2020 | 131.67M |
| Date | Value |
|---|---|
| March 31, 2020 | 142.12M |
| December 31, 2019 | 156.90M |
| September 30, 2019 | 168.67M |
| June 30, 2019 | 180.82M |
| March 31, 2019 | 112.21M |
| December 31, 2018 | 124.10M |
| September 30, 2018 | 135.03M |
| June 30, 2018 | 144.62M |
| March 31, 2018 | 128.77M |
| December 31, 2017 | 85.04M |
| September 30, 2017 | 95.56M |
| June 30, 2017 | 46.70M |
| March 31, 2017 | 55.75M |
| December 31, 2016 | 13.50M |
| September 30, 2016 | 68.64M |
| June 30, 2016 | 73.51M |
| March 31, 2016 | 78.90M |
| December 31, 2015 | 85.02M |
| September 30, 2015 | 33.10M |
| June 30, 2015 | 39.09M |
| March 31, 2015 | 38.27M |
| December 31, 2014 | 7.326M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 17.26M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Agenus, Inc. | -199.08M |
| Amgen, Inc. | 11.69B |
| Anika Therapeutics, Inc. | 137.28M |
| BioCryst Pharmaceuticals, Inc. | -454.29M |
| Imunon, Inc. | 4.189M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 13.48M |
| Total Liabilities (Quarterly) | 1.461M |
| Current Ratio | 9.191 |